[go: up one dir, main page]

GB1269616A - Improvements in pharmaceutical compositions - Google Patents

Improvements in pharmaceutical compositions

Info

Publication number
GB1269616A
GB1269616A GB4254570A GB4254570A GB1269616A GB 1269616 A GB1269616 A GB 1269616A GB 4254570 A GB4254570 A GB 4254570A GB 4254570 A GB4254570 A GB 4254570A GB 1269616 A GB1269616 A GB 1269616A
Authority
GB
United Kingdom
Prior art keywords
nitrofurantoin
amount
deglycyrrhizinized
liquorice
sept
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4254570A
Inventor
Gerardus Van Loon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cedona Haarlemmer Pharmaceutsiche Fabriek
Original Assignee
Cedona Haarlemmer Pharmaceutsiche Fabriek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedona Haarlemmer Pharmaceutsiche Fabriek filed Critical Cedona Haarlemmer Pharmaceutsiche Fabriek
Publication of GB1269616A publication Critical patent/GB1269616A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

1,269,616. Antibacterial compositions. CEDONA HAARLEMMER PHARMACEUTISCHE FABRIEK N.V. 4 Sept., 1970 [12 Sept., 1969], No. 42545/70. Heading A5B. Antibacterial compositions comprise an effective amount of nitrofurantoin and deglycyrrhizinized liquorice in an amount sufficient to reduce the side effects of the nitrofurantoin. The deglycyrrhizinized liquorice may be present in an amount of one fourth to ten times the amount of nitrofurantoin, by weight. The compositions may be administered orally in the form of tablets or capsules particularly in the treatment of urinary tract infections.
GB4254570A 1969-09-12 1970-09-04 Improvements in pharmaceutical compositions Expired GB1269616A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85754869A 1969-09-12 1969-09-12

Publications (1)

Publication Number Publication Date
GB1269616A true GB1269616A (en) 1972-04-06

Family

ID=25326241

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4254570A Expired GB1269616A (en) 1969-09-12 1970-09-04 Improvements in pharmaceutical compositions

Country Status (6)

Country Link
AT (1) AT304759B (en)
DE (1) DE2037719C3 (en)
ES (1) ES383595A1 (en)
FR (1) FR2064060B1 (en)
GB (1) GB1269616A (en)
NL (1) NL7000491A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2536279A1 (en) * 1982-11-22 1984-05-25 Inst Organicheskogo Sinteza Ak Antibacterial drug based on a potassium salt of N-[ beta -(5'-nitro-2'-furyl)acrylidene-1-aminohydantoin
US4423027A (en) 1982-12-22 1983-12-27 Simon Lionel N Pharmaceutical compositions of deglycyrrhizinated licorice (DGL)

Also Published As

Publication number Publication date
FR2064060B1 (en) 1974-02-22
ES383595A1 (en) 1973-01-01
DE2037719A1 (en) 1971-03-18
NL7000491A (en) 1971-03-16
FR2064060A1 (en) 1971-07-16
DE2037719C3 (en) 1982-07-22
AT304759B (en) 1973-01-25
DE2037719B2 (en) 1979-11-29

Similar Documents

Publication Publication Date Title
ES403435A1 (en) Slow release pharmaceutical compositions
IL37385A (en) Benzyl-imidazoles and 1,2,4-triazoles,their production and pharmaceutical compositions containing them
IL36299A0 (en) 3-octadecyloxypropyl-2'-trimethylammoniumethyl phosphate,its preparation and pharmaceutical compositions containing it
IL35729A0 (en) 2-(5-nitro-2-furyl)-thieno (3.2-d) pyrimidines,their preparation and pharmaceutical compositions containing them
IL37984A0 (en) 2,4-diamino-5-benzylpyrimidine derivatives,their preparation and pharmaceutical compositions containing them
CA972749A (en) Derivatives of 9-oxo-15-hydroxyprostanoic acid, homologs thereof and their preparation
AU8251275A (en) Pharmaceutical compositions comprising 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid, and their uses
ZA71221B (en) New pharmaceutical compositions for the treatment of microbial infections
Hartmann Amitriptyline and imipramine: effects on human sleep.
GB1269616A (en) Improvements in pharmaceutical compositions
IL37013A (en) Basically substituted alkylidene-aminooxyalkyl-carboxylic acid esters,their preparation and pharmaceutical compositions containing them
IL35490A (en) 6-amidino-penicillanic acid derivatives,their preparation and pharmaceutical compositions containing them
GB1125924A (en) Organic bismuth derivative
GB1300486A (en) Compositions for the treatment of respiratory ailments in man
IL37900A0 (en) Thiazolone-(2)derivatives,their preparation,and pharmaceutical compositions containing them
IL38199A0 (en) 2-acryloyl benzimidazoles,their preparation and pharmaceutical compositions containing them
GB1289039A (en)
GB1036059A (en) Improvements in or relating to the inhibition of bacterial growth
GB976096A (en) Pharmaceutical compositions
GB1157662A (en) Improvements in or relating to Pharmaceutical Compositions
IL34937A0 (en) 2,2'-azines of 3-substituted 2,4-thiazolidinediones,their preparation and pharmaceutical compositions containing them
IL34158A (en) Adamantylcarboxamidophenylacetic acid and its derivatives, their preparation and pharmaceutical compositions containing them
GB1242306A (en) A synergistic pharmaceutical composition suitable for the treatment of certain pathological venous conditions
IE32617L (en) Pharmaceutical composition
GB1279185A (en) Improvements in or relating to pharmaceutical compositions